Erythropoietin, forkhead proteins, and oxidative injury: Biomarkers and biology

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 1072-1104

  Maiese, Kenneth ^a   Hou, Jinling ^a   Chong, Zhao Zhong ^a   Shang, Yan Chen ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Angiogenesis; Apoptosis; Cancer; Cardiac; Diabetes; Erythropoietin; Forkhead transcription factors; Immune system; Ischemia; Neurodegeneration; Oxidative stress; Sirtuins; Stem cells; Vascular disease; Wingless; Wnt

Indexed keywords

BIOLOGICAL MARKER; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; GROWTH FACTOR; IMATINIB;

ANEMIA; ANGIOGENESIS; CANCER CELL; CANCER INVASION; CELL DEGENERATION; CELL INVASION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MARKER; DRUG FEVER; DRUG TARGETING; DYSPNEA; HEART INFARCTION; HUMAN; IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PARESTHESIA; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; THROMBOSIS; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ANIMALS; BIOLOGICAL MARKERS; CELL SURVIVAL; DIABETES MELLITUS; ERYTHROPOIETIN; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; RECEPTORS, ERYTHROPOIETIN;

MAMMALIA;

EID: 76749124191     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.121     Document Type: Review

References (409)

1. Chong, Z.Z., Li, F., and Maiese, K. (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog. Neurobiol. 75, 207-246.
2. Maiese, K. (2008) Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus. Biomed. Pharmacother. 62, 218-232.
3. Maiese, K., Chong, Z.Z., Hou, J., and Shang, Y.C. (2008) Erythropoietin and oxidative stress. Curr. Neurovasc. Res. 5, 125-142.
4. Regulska, M., Leskiewicz, M., Budziszewska, B., Kutner, A., Jantas, D., Basta-Kaim, A., Kubera, M., Jaworska-Feil, L., and Lason, W. (2007) Inhibitory effects of 1,25-dihydroxyvitamin D(3) and its low-calcemic analogues on staurosporine-induced apoptosis. Pharmacol. Rep. 59, 393-401.
5. Chlopicki, S., Swies, J., Mogielnicki, A., Buczko, W., Bartus, M., Lomnicka, M., Adamus, J., and Gebicki, J. (2007) 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br. J. Pharmacol. 152, 230-239.
6. Chong, Z.Z., Lin, S.H., and Maiese, K. (2002) Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J. Vasc. Res. 39, 131-147.
7. Feng, Y., Paul, I.A., and LeBlanc, M.H. (2006) Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat. Brain Res. Bull. 69, 117-122.
8. Hara, N., Yamada, K., Shibata, T., Osago, H., Hashimoto, T., and Tsuchiya, M. (2007) Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J. Biol. Chem. 282, 24574-24582.
9. Ieraci, A. and Herrera, D.G. (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med. 3, e101.
10. Lin, S.H., Vincent, A., Shaw, T., Maynard, K.I., and Maiese, K. (2000) Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J. Cereb. Blood Flow Metab. 20, 1380-1391.
11. Maiese, K. and Chong, Z.Z. (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 24, 228-232.
12. Pearl, R. (1928) The Rate of Living. University of London Press, London.
13. Muller, F.L., Lustgarten, M.S., Jang, Y., Richardson, A., and Van Remmen, H. (2007) Trends in oxidative aging theories. Free Radic. Biol. Med. 43, 477-503.
14. Yui, R. and Matsuura, E.T. (2006) Detection of deletions flanked by short direct repeats in mitochondrial DNA of aging Drosophila. Mutat. Res. 594, 155-161.
15. Chong, Z.Z., Li, F., and Maiese, K. (2006) Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3. Curr. Neurovasc. Res. 3, 25-39.
16. De Felice, F.G., Velasco, P.T., Lambert, M.P., Viola, K., Fernandez, S.J., Ferreira, S.T., and Klein, W.L. (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590-11601.
17. Lin, S.H. and Maiese, K. (2001) The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. J. Cereb. Blood Flow Metab. 21, 262-275.
18. Lee, S.J., Cho, K.S., and Koh, J.Y. (2009) Oxidative injury triggers autophagy in astrocytes: the role of endogenous zinc. Glia 57, 1351-1361.
19. Cohen, S.M., Cordeiro-Stone, M., and Kaufman, D.G. (2007) Early replication and the apoptotic pathway. J. Cell. Physiol. 213, 434-439.
20. He, X.L., Wang, Y.H., Gao, M., Li, X.X., Zhang, T.T., and Du, G.H. (2009) Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage. Brain Res. 1249, 212-221.
21. Maiese, K., Chong, Z.Z., Shang, Y.C., and Hou, J. (2008) Therapeutic promise and principles: metabotropic glutamate receptors. Oxid. Med. Cell. Longev. 1, 1-14.
22. Plecita-Hlavata, L., Lessard, M., Santorova, J., Bewersdorf, J., and Jezek, P. (2008) Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. Biochim. Biophys. Acta 1777, 834-846.
23. Chong, Z.Z., Li, F., and Maiese, K. (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res. Brain Res. Rev. 49, 1-21.
24. Guglielmotto, M., Tamagno, E., and Danni, O. (2009) Oxidative stress and hypoxia contribute to Alzheimer's disease pathogenesis: two sides of the same coin. TheScientificWorldJOURNAL 9, 781-791.
25. Soo, E.T., Ng, Y.K., Bay, B.H., and Yip, G.W. (2008) Heat shock proteins and neurodegenerative disorders. TheScientificWorldJOURNAL 8, 270-274.
26. Nagley, P., Higgins, G.C., Atkin, J.D., and Beart, P.M. (2009) Multifaceted deaths orchestrated by mitochondria in neurones. Biochim. Biophys. Acta [Epub ahead of print]
27. Harris, S.E., Fox, H., Wright, A.F., Hayward, C., Starr, J.M., Whalley, L.J., and Deary, I.J. (2007) A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet. 8, 43.
28. Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., Strosznajder, J.B., Eckert, A., and Muller, W.E. (2007) Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid. Redox Signal. 9, 1659-1675.
29. Okouchi, M., Ekshyyan, O., Maracine, M., and Aw, T.Y. (2007) Neuronal apoptosis in neurodegeneration. Antioxid. Redox Signal. 9, 1059-1096.
30. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2004) Akt1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-x(L) and caspase 1, 3, and 9. Exp. Cell Res. 296, 196-207.
31. Chong, Z.Z., Li, F., and Maiese, K. (2007) The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. Int. J. Mol. Med. 19, 263-272.
32. Kang, J.Q., Chong, Z.Z., and Maiese, K. (2003) Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol. Pharmacol. 64, 557-569.
33. Karunakaran, S., Diwakar, L., Saeed, U., Agarwal, V., Ramakrishnan, S., Iyengar, S., and Ravindranath, V. (2007) Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. FASEB J. 21, 2226-2236.
34. Verdaguer, E., Susana Gde, A., Clemens, A., Pallas, M., and Camins, A. (2007) Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis. Biomed. Pharmacother. 61, 390-399.
35. Chong, Z.Z., Li, F., and Maiese, K. (2005) Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better? Curr. Neurovasc. Res. 2, 55-72.
36. Maiese, K., Chong, Z.Z., Shang, Y.C., and Hou, J. (2008) Rogue proliferation versus restorative protection: where do we draw the line for Wnt and forkhead signaling? Expert Opin. Ther. Targets 12, 905-916.
37. Maiese, K., Vincent, A., Lin, S.H., and Shaw, T. (2000) Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection. J. Neurosci. Res. 62, 257-272.
38. Mari, C., Karabiyikoglu, M., Goris, M.L., Tait, J.F., Yenari, M.A., and Blankenberg, F.G. (2004) Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V. Eur. J. Nucl. Med. Mol. Imaging 31, 733-739.
39. Chong, Z.Z., Kang, J., Li, F., and Maiese, K. (2005) mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. Curr. Neurovasc. Res. 2, 197-211.
40. Li, F., Chong, Z.Z., and Maiese, K. (2006) Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. Curr. Neurovasc. Res. 3, 187-201.
41. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2003) Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. Histol. Histopathol. 18, 173-189.
42. Kang, J.Q., Chong, Z.Z., and Maiese, K. (2003) Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity. J. Neurosci. Res. 74, 37-51.
43. Mallat, M., Marin-Teva, J.L., and Cheret, C. (2005) Phagocytosis in the developing CNS: more than clearing the corpses. Curr. Opin. Neurobiol. 15, 101-107.
44. Li, F., Chong, Z.Z., and Maiese, K. (2006) Cell life versus cell longevity: the mysteries surrounding the NAD(+) precursor nicotinamide. Curr. Med. Chem. 13, 883-895.
45. Li, F., Chong, Z.Z., and Maiese, K. (2006) Winding through the WNT pathway during cellular development and demise. Histol. Histopathol. 21, 103-124.
46. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2003) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br. J. Pharmacol. 138, 1107-1118.
47. Maiese, K., Ahmad, I., TenBroeke, M., and Gallant, J. (1999) Metabotropic glutamate receptor subtypes independently modulate neuronal intracellular calcium. J. Neurosci. Res. 55, 472-485.
48. Vincent, A.M. and Maiese, K. (1999) Direct temporal analysis of apoptosis induction in living adherent neurons. J. Histochem. Cytochem. 47, 661-672.
49. Chong, Z.Z., Li, F., and Maiese, K. (2007) Cellular demise and inflammatory microglial activation during betaamyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal. 19, 1150-1162.
50. Shang, Y.C., Chong, Z.Z., Hou, J., and Maiese, K. (2009) The forkhead transcription factor FoxO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. Curr. Neurovasc. Res. 6, 20-31.
51. Chong, Z.Z., Lin, S.H., Kang, J.Q., and Maiese, K. (2003) Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71, 659-669.
52. Chong, Z.Z., Lin, S.H., Kang, J.Q., and Maiese, K. (2003) The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival. Cell. Mol. Neurobiol. 23, 561-578.
53. Maiese, K. and Boccone, L. (1995) Neuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C. J. Cereb. Blood Flow Metab. 15, 440-449.
54. Maiese, K., Boniece, I.R., Skurat, K., and Wagner, J.A. (1993) Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia. J. Neurosci. Res. 36, 77-87.
55. Maiese, K., TenBroeke, M., and Kue, I. (1997) Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J. Neurochem. 68, 710-714.
56. Salinas, M., Diaz, R., Abraham, N.G., Ruiz de Galarreta, C.M., and Cuadrado, A. (2003) Nerve growth factor protects against 6-hydroxydopamine- induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278, 13898-13904.
57. Leytin, V., Allen, D.J., Mykhaylov, S., Lyubimov, E., and Freedman, J. (2006) Thrombin-triggered platelet apoptosis. J. Thromb. Haemost. 4, 2656-2663.
58. Maiese, K. and Vincent, A.M. (2000) Critical temporal modulation of neuronal programmed cell injury. Cell. Mol. Neurobiol. 20, 383-400.
59. Maiese, K. and Vincent, A.M. (2000) Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death. J. Neurosci. Res. 59, 568-580.
60. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2004) Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid. Redox Signal. 6, 277-287.
61. Dombroski, D., Balasubramanian, K., and Schroit, A.J. (2000) Phosphatidylserine expression on cell surfaces promotes antibody- dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice. J. Autoimmun. 14, 221-229.
62. Jessel, R., Haertel, S., Socaciu, C., Tykhonova, S., and Diehl, H.A. (2002) Kinetics of apoptotic markers in exogeneously induced apoptosis of EL4 cells. J. Cell. Mol. Med. 6, 82-92.
63. Chong, Z.Z. and Maiese, K. (2007) The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol. Histopathol. 22, 1251-1267.
64. Vincent, A.M. and Maiese, K. (1999) Nitric oxide induction of neuronal endonuclease activity in programmed cell death. Exp. Cell Res. 246, 290-300.
65. Vincent, A.M., TenBroeke, M., and Maiese, K. (1999) Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH. Exp. Neurol. 155, 79-94.
66. Di Lisa, F., Menabo, R., Canton, M., Barile, M., and Bernardi, P. (2001) Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571-2575.
67. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2003) Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J. Cereb. Blood Flow Metab. 23, 320-330.
68. Chong, Z.Z., Lin, S.H., Li, F., and Maiese, K. (2005) The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through Akt, Bad, PARP, and mitochondrial associated "anti- apoptotic" pathways. Curr. Neurovasc. Res. 2, 271-285.
69. Maiese, K. and Chong, Z.Z. (2004) Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor. Neurol. Neurosci. 22, 87-104.
70. Li, F., Chong, Z.Z., and Maiese, K. (2004) Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. Front. Biosci. 9, 2500-2520.
71. Wilson, F.H., Hariri, A., Farhi, A., Zhao, H., Petersen, K.F., Toka, H.R., Nelson-Williams, C., Raja, K.M., Kashgarian, M., Shulman, G.I., Scheinman, S.J., and Lifton, R.P. (2004) A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306, 1190-1194.
72. Roberts, E., Jr. and Chih, C.P. (1997) The influence of age of pH regulation in hippocampal slices before, during, and after anoxia. J. Cereb. Blood Flow Metab. 17, 560-566.
73. Cardella, F. (2005) Insulin therapy during diabetic ketoacidosis in children. Acta Biomed. 76(Suppl 3), 49-54.
74. Kratzsch, J., Knerr, I., Galler, A., Kapellen, T., Raile, K., Korner, A., Thiery, J., Dotsch, J., and Kiess, W. (2006) Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur. J. Endocrinol. 155, 609-614.
75. Ito, N., Bartunek, J., Spitzer, K.W., and Lorell, B.H. (1997) Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95, 2303-2311.
76. Vincent, A.M., TenBroeke, M., and Maiese, K. (1999) Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death. J. Neurobiol. 40, 171-184.
77. Maiese, K. (2009) Marking the onset of oxidative stress: biomarkers and novel strategies. Oxid. Med. Cell. Longev. 2, 1.
78. Maiese, K., Chong, Z.Z., Li, F., and Shang, Y.C. (2008) Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog. Neurobiol. 85, 194-213.
79. Maiese, K., Chong, Z.Z., and Shang, Y.C. (2008) Raves and risks for erythropoietin. Cytokine Growth Factor Rev. 19, 145-155.
80. Maiese, K., Li, F., and Chong, Z.Z. (2005) New avenues of exploration for erythropoietin. JAMA 293, 90-95.
81. Maiese, K., Chong, Z.Z., and Shang, Y.C. (2008) OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol. Med. 14, 219-227.
82. Maiese, K., Chong, Z.Z., Shang, Y.C., and Hou, J. (2009) FoxO proteins: cunning concepts and considerations for the cardiovascular system. Clin. Sci. (Lond.) 116, 191-203.
83. Maiese, K., Chong, Z.Z., Shang, Y.C., and Hou, J. (2009) A "FOXO" in sight: targeting Foxo proteins from conception to cancer. Med. Res. Rev. 29, 395-418.
84. Maiese, K., Li, F., and Chong, Z.Z. (2005) Erythropoietin and cancer. JAMA 293, 1858-1859.
85. Bloomer, R. and Fisher-Wellman, K. (2009) Systemic oxidative stress is increased to a greater degree in young, obese women following consumption of a high fat meal. Oxid. Med. Cell. Longev. 2, 19-25.
86. Fisher-Wellman, K., Bell, H., and Bloomer, R. (2009) Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxid. Med. Cell. Longev. 2, 43-51.
87. Carnot, P. and DeFlandre, C. (1906) Sur l'activite hemopoietique de serum au cours de la regeneration du sang. C. R. Acad. Sci. (Paris) 143, 384-386.
88. Fisher, J.W. (2003) Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228, 1-14.
89. Erslev, A.J. (1974) In vitro production of erythropoietin by kidneys perfused with a serum-free solution. Blood 44, 77-85.
90. Gibelli, C. (1911) Uber den wert des serums anamisch gemachten tiere bei der regeneration des blutes. Arch. Exp. Pathol. Pharmacol. 65, 284-302.
91. Sandor, G. (1932) Uber die blutbidende wirkung des serums von tieren, die in verdunnter luft gehalten wuren. Z. Gesante Exp. Med. 82, 633-646.
92. Reissmann, K. (1950) Studies on the mechanism of erythropoietin stimulation in parabiotic rats during hypoxia. Blood 5, 347-380.
93. Jacobs, K., Shoemaker, C., Rudersdorf, R., Neill, S.D., Kaufman, R.J., Mufson, A., Seehra, J., Jones, S.S., Hewick, R., Fritsch, E.F., Kawakita, M., Shimizu, T., and Miyake, T. (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313, 806-810.
94. Lin, F.K., Suggs, S., Lin, C.H., Browne, J.K., Smalling, R., Egrie, J.C., Chen, K.K., Fox, G.M., Martin, F., Stabinsky, Z., Badrawi, S., Lai, P.-H., and Goldwasser, E. (1985) Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 82, 7580-7584.
95. Maiese, K., Li, F., and Chong, Z.Z. (2004) Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol. Sci. 25, 577-583.
96. Toyoda, T., Itai, T., Arakawa, T., Aoki, K.H., and Yamaguchi, H. (2000) Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J. Biochem. (Tokyo) 128, 731-737.
97. Uchida, E., Morimoto, K., Kawasaki, N., Izaki, Y., Abdu Said, A., and Hayakawa, T. (1997) Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin. Free Radic. Res. 27, 311-323.
98. Tsuda, E., Goto, M., Murakami, A., Akai, K., Ueda, M., Kawanishi, G., Takahashi, N., Sasaki, R., Chiba, H., Ishihara, H., Mori, M., Tejima, S., Endo, S., and Arata, Y. (1988) Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. Biochemistry 27, 5646-5654.
99. Krantz, S.B. (1991) Erythropoietin. Blood 77, 419-434.
100. Tsuda, E., Kawanishi, G., Ueda, M., Masuda, S., and Sasaki, R. (1990) The role of carbohydrate in recombinant human erythropoietin. Eur. J. Biochem. 188, 405-411.
101. Fliser, D. and Haller, H. (2007) Erythropoietin and treatment of non-anemic conditions--cardiovascular protection. Semin. Hematol. 44, 212-217.
102. Lacombe, C., Da Silva, J.L., Bruneval, P., Casadevall, N., Camilleri, J.P., Bariety, J., Tambourin, P., and Varet, B. (1991) Erythropoietin: sites of synthesis and regulation of secretion. Am. J. Kidney Dis. 18, 14-19.
103. Mujais, S.K., Beru, N., Pullman, T.N., and Goldwasser, E. (1999) Erythropoietin is produced by tubular cells of the rat kidney. Cell Biochem. Biophys. 30, 153-166.
104. Chang, Y.K., Choi, D.E., Na, K.R., Lee, S.J., Suh, K.S., Kim, S.Y., Shin, Y.T., and Lee, K.W. (2009) Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and antiapoptotic effects. J. Urol. 181, 1434-1443.
105. Sharples, E.J., Thiemermann, C., and Yaqoob, M.M. (2005) Mechanisms of disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat. Clin. Pract. Nephrol. 1, 87-97.
106. Sharples, E.J. and Yaqoob, M.M. (2006) Erythropoietin in experimental acute renal failure. Nephron Exp. Nephrol. 104, e83-88.
107. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2002) Angiogenesis and plasticity: role of erythropoietin in vascular systems. J. Hematother. Stem Cell Res. 11, 863-871.
108. Schmeding, M., Boas-Knoop, S., Lippert, S., Ruehl, M., Somasundaram, R., Dagdelen, T., Neuhaus, P., and Neumann, U.P. (2008) Erythropoietin promotes hepatic regeneration after extended liver resection in rats. J. Gastroenterol. Hepatol. 23, 1125-1131.
109. Schmeding, M., Neumann, U.P., Boas-Knoop, S., Spinelli, A., and Neuhaus, P. (2007) Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur. Surg. Res. 39, 189-197.
110. Davis, L.E., Widness, J.A., and Brace, R.A. (2003) Renal and placental secretion of erythropoietin during anemia or hypoxia in the ovine fetus. Am. J. Obstet. Gynecol. 189, 1764-1770.
111. Teramo, K.A. and Widness, J.A. (2009) Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxia. Neonatology 95, 105-116.
112. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973-2979.
113. Chong, Z.Z. and Maiese, K. (2007) Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br. J. Pharmacol. 150, 839-850.
114. Mikati, M.A., Hokayem, J.A., and Sabban, M.E. (2007) Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at p10. Epilepsia 48, 175-181.
115. Moon, C., Krawczyk, M., Paik, D., Coleman, T., Brines, M., Juhaszova, M., Sollott, S.J., Lakatta, E.G., and Talan, M.I. (2006) Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J. Pharmacol. Exp. Ther. 316, 999-1005.
116. Um, M., Gross, A.W., and Lodish, H.F. (2007) A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell. Signal. 19, 634-645.
117. Arcasoy, M.O. (2008) The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 141, 14-31.
118. Schumann, C., Triantafilou, K., Krueger, S., Hombach, V., Triantafilou, M., Becher, G., and Lepper, P.M. (2006) Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array. Mediators Inflamm. 2006, 18061.
119. Kaindl, A.M., Sifringer, M., Koppelstaetter, A., Genz, K., Loeber, R., Boerner, C., Stuwe, J., Klose, J., and Felderhoff-Mueser, U. (2008) Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann. Neurol. 64, 523-534.
120. Yis, U., Kurul, S.H., Kumral, A., Tugyan, K., Cilaker, S., Yilmaz, O., Genc, S., and Genc, K. (2008) Effect of erythropoietin on oxygen-induced brain injury in the newborn rat. Neurosci. Lett. 448, 245-249.
121. He, Z., Huang, L., Wu, Y., Wang, J., Wang, H., and Guo, L. (2008) DDPH: improving cognitive deficits beyond its alpha 1-adrenoceptor antagonism in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 588, 178-188.
122. Berkingali, N., Warnecke, A., Gomes, P., Paasche, G., Tack, J., Lenarz, T., and Stover, T. (2008) Neurite outgrowth on cultured spiral ganglion neurons induced by erythropoietin. Hear. Res. 243, 121-126.
123. Shah, R.C., Wilson, R.S., Tang, Y., Dong, X., Murray, A., and Bennett, D.A. (2009) Relation of hemoglobin to level of cognitive function in older persons. Neuroepidemiology 32, 40-46.
124. Bierer, R., Peceny, M.C., Hartenberger, C.H., and Ohls, R.K. (2006) Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118, e635-640.
125. Pillai, A., Dhandapani, K.M., Pillai, B.A., Terry, A.V., Jr., and Mahadik, S.P. (2008) Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF. Neuropsychopharmacology 33, 1942-1951.
126. McLeod, M., Hong, M., Mukhida, K., Sadi, D., Ulalia, R., and Mendez, I. (2006) Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur. J. Neurosci. 24, 361-370.
127. Assaraf, M.I., Diaz, Z., Liberman, A., Miller, W.H., Jr., Arvanitakis, Z., Li, Y., Bennett, D.A., and Schipper, H.M. (2007) Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J. Neuropathol. Exp. Neurol. 66, 389-398.
128. Palazzuoli, A., Silverberg, D., Iovine, F., Capobianco, S., Giannotti, G., Calabro, A., Campagna, S.M., and Nuti, R. (2006) Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am. Heart J. 152, 1096.e9-15.
129. Palazzuoli, A., Silverberg, D.S., Iovine, F., Calabro, A., Campagna, M.S., Gallotta, M., and Nuti, R. (2007) Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am. Heart J. 154, 645.e9-15.
130. Smith, K., Semple, D., Bhandari, S., and Seymour, A.M. (2009) Cellular basis of uraemic cardiomyopathy: a role for erythropoietin? Eur. J. Heart Fail. 11, 732-738.
131. Gleissner, C.A., Klingenberg, R., Staritz, P., Koch, A., Ehlermann, P., Wiggenhauser, A., and Dengler, T.J. (2006) Role of erythropoietin in anemia after heart transplantation. Int. J. Cardiol. 112, 341-347.
132. Mocini, D., Leone, T., Tubaro, M., Santini, M., and Penco, M. (2007) Structure, production and function of erythropoietin: implications for therapeutical use in cardiovascular disease. Curr. Med. Chem. 14, 2278-2287.
133. Song, Y.R., Lee, T., You, S.J., Chin, H.J., Chae, D.W., Lim, C., Park, K.H., Han, S., Kim, J.H., and Na, K.Y. (2009) Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am. J. Nephrol. 30, 253-260.
134. Digicaylioglu, M., Garden, G., Timberlake, S., Fletcher, L., and Lipton, S.A. (2004) Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 101, 9855-9860.
135. Genc, S., Koroglu, T.F., and Genc, K. (2004) Erythropoietin as a novel neuroprotectant. Restor. Neurol. Neurosci. 22, 105-119.
136. Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E.S., Kessimian, N., and Noguchi, C.T. (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 91, 3974-3978.
137. Ogilvie, M., Yu, X., Nicolas-Metral, V., Pulido, S.M., Liu, C., Ruegg, U.T., and Noguchi, C.T. (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J. Biol. Chem. 275, 39754-39761.
138. Fenjves, E.S., Ochoa, M.S., Cabrera, O., Mendez, A.J., Kenyon, N.S., Inverardi, L., and Ricordi, C. (2003) Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Transplantation 75, 1356-1360.
139. Sanchez, P.E., Navarro, F.P., Fares, R.P., Nadam, J., Georges, B., Moulin, C., Le Cavorsin, M., Bonnet, C., Ryvlin, P., Belmeguenai, A., Bodennec, J., Morales, A., and Bezin, L. (2009) Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J. Comp. Neurol. 514, 403-414.
140. Hassan, K., Gross, B., Simri, W., Rubinchik, I., Cohen, H., Jacobi, J., Shasha, S.M., and Kristal, B. (2004) The presence of erythropoietin receptors in the human peripheral nervous system. Clin. Nephrol. 61, 127-129.
141. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22, 503-514.
142. Yamaji, R., Okada, T., Moriya, M., Naito, M., Tsuruo, T., Miyatake, K., and Nakano, Y. (1996) Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 239, 494-500.
143. Maiese, K., Chong, Z., and Li, F. (2009) Reducing oxidative stress and enhancing neurovascular longevity during diabetes mellitus. In Neurovascular Medicine: Pursuing Cellular Longevity for Healthy Aging. Maiese, K, Ed. Oxford University Press, New York. pp. 540-564.
144. Yasuda, Y., Masuda, S., Chikuma, M., Inoue, K., Nagao, M., and Sasaki, R. (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J. Biol. Chem. 273, 25381-25387.
145. Masuda, S., Kobayashi, T., Chikuma, M., Nagao, M., and Sasaki, R. (2000) The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner. Am. J. Physiol. Endocrinol. Metab. 278, E1038-1044.
146. Chikuma, M., Masuda, S., Kobayashi, T., Nagao, M., and Sasaki, R. (2000) Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am. J. Physiol. Endocrinol. Metab. 279, E1242-1248.
147. Obara, N., Imagawa, S., Nakano, Y., Suzuki, N., Yamamoto, M., and Nagasawa, T. (2003) Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1, not stimulation of GATA-2. Arch. Toxicol. 77, 267-273.
148. Li, C.L., Jiang, J., Fan, Y.Q., Fu, G.S., Wang, J.A., and Fan, W.M. (2009) Knockout of the tumor necrosis factor a receptor 1 gene can up-regulate erythropoietin receptor during myocardial ischemia-reperfusion injury in mice. Chin. Med. J. (Engl.) 122, 566-570.
149. Nagai, A., Nakagawa, E., Choi, H.B., Hatori, K., Kobayashi, S., and Kim, S.U. (2001) Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60, 386-392.
150. Pregi, N., Wenker, S., Vittori, D., Leiros, C.P., and Nesse, A. (2009) TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells. Exp. Cell Res. 315, 419-431.
151. Clark, K.L., Halay, E.D., Lai, E., and Burley, S.K. (1993) Co-crystal structure of the HNF-3/fork head DNArecognition motif resembles histone H5. Nature 364, 412-420.
152. Larson, E.T., Eilers, B., Menon, S., Reiter, D., Ortmann, A., Young, M.J., and Lawrence, C.M. (2007) A wingedhelix protein from Sulfolobus turreted icosahedral virus points toward stabilizing disulfide bonds in the intracellular proteins of a hyperthermophilic virus. Virology 368, 249-261.
153. Jin, C., Marsden, I., Chen, X., and Liao, X. (1998) Sequence specific collective motions in a winged helix DNA binding domain detected by 15N relaxation NMR. Biochemistry 37, 6179-6187.
154. Tsai, K.L., Sun, Y.J., Huang, C.Y., Yang, J.Y., Hung, M.C., and Hsiao, C.D. (2007) Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res. 35, 6984-6994.
155. Wijchers, P.J., Burbach, J.P., and Smidt, M.P. (2006) In control of biology: of mice, men and Foxes. Biochem. J. 397, 233-246.
156. Weigel, D., Jurgens, G., Kuttner, F., Seifert, E., and Jackle, H. (1989) The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57, 645-658.
157. Kaestner, K.H., Knochel, W., and Martinez, D.E. (2000) Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14, 142-146.
158. Maiese, K., Chong, Z.Z., and Shang, Y.C. (2007) "Sly as a FOXO": new paths with forkhead signaling in the brain. Curr. Neurovasc. Res. 4, 295-302.
159. Parry, P., Wei, Y., and Evans, G. (1994) Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes Chromosomes Cancer 11, 79-84.
160. Hillion, J., Le Coniat, M., Jonveaux, P., Berger, R., and Bernard, O.A. (1997) AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90, 3714-3719.
161. Castrillon, D.H., Miao, L., Kollipara, R., Horner, J.W., and DePinho, R.A. (2003) Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301, 215-218.
162. Furuyama, T., Nakazawa, T., Nakano, I., and Mori, N. (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349, 629-634.
163. Furuyama, T., Yamashita, H., Kitayama, K., Higami, Y., Shimokawa, I., and Mori, N. (2002) Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles. Microsc. Res. Tech. 59, 331-334.
164. Hoekman, M.F., Jacobs, F.M., Smidt, M.P., and Burbach, J.P. (2006) Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr. Patterns 6, 134-140.
165. Lappas, M., Lim, R., Riley, C., Rice, G.E., and Permezel, M. (2009) Localisation and expression of FoxO1 proteins in human gestational tissues. Placenta 30, 256-262.
166. Maiese, K., Chong, Z., Hou, J., and Shang, Y. (2009) The "O" class: crafting clinical care with FoxO transcription factors. In Forkhead Transcription Factors: Vital Elements in Biology and Medicine. Maiese, K., Ed. Landes Bioscience, Austin, TX.
167. Modur, V., Nagarajan, R., Evers, B.M., and Milbrandt, J. (2002) FOXO proteins regulate tumor necrosis factorrelated apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J. Biol. Chem. 277, 47928-47937.
168. Biggs, W.H., 3rd, Cavenee, W.K., and Arden, K.C. (2001) Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 12, 416-425.
169. Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., and Fukamizu, A. (2003) Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. U. S. A. 100, 11285-11290.
170. Plas, D.R. and Thompson, C.B. (2003) Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J. Biol. Chem. 278, 12361-12366.
171. Jagani, Z., Singh, A., and Khosravi-Far, R. (2008) FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis. Biochim. Biophys. Acta 1785, 63-84.
172. Maiese, K., Chong, Z.Z., Shang, Y.C., and Hou, J. (2008) Clever cancer strategies with FoxO transcription factors. Cell Cycle 7, 3829-3839.
173. van der Horst, A. and Burgering, B.M. (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8, 440-450.
174. Taylor, D.M., Maxwell, M.M., Luthi-Carter, R., and Kazantsev, A.G. (2008) Biological and potential therapeutic roles of sirtuin deacetylases. Cell. Mol. Life Sci. 65, 4000-4018.
175. Zschoernig, B. and Mahlknecht, U. (2008) SIRTUIN 1: regulating the regulator. Biochem. Biophys. Res. Commun. 376, 251-255.
176. Matsuzaki, H., Daitoku, H., Hatta, M., Aoyama, H., Yoshimochi, K., and Fukamizu, A. (2005) Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 102, 11278-11283.
177. Song, M., Park, J.E., Park, S.G., Lee do, H., Choi, H.K., Park, B.C., Ryu, S.E., Kim, J.H., and Cho, S. (2009) NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26). Biochem. Biophys. Res. Commun. 381, 491-495.
178. Chong, Z.Z., Li, F., and Maiese, K. (2005) Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol. Histopathol. 20, 299-315.
179. Leong, M.L., Maiyar, A.C., Kim, B., O'Keeffe, B.A., and Firestone, G.L. (2003) Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J. Biol. Chem. 278, 5871-5882.
180. Lehtinen, M.K., Yuan, Z., Boag, P.R., Yang, Y., Villen, J., Becker, E.B., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T.K., and Bonni, A. (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125, 987-1001.
181. Song, J.J. and Lee, Y.J. (2008) Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily. Cell. Signal. 20, 892-906.
182. Gayer, C.P., Chaturvedi, L.S., Wang, S., Craig, D.H., Flanigan, T., and Basson, M.D. (2009) Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway. J. Biol. Chem. 284, 2001-2011.
183. An, J., Zhang, C., Polavarapu, R., Zhang, X., and Yepes, M. (2008) Tissue-type plasminogen activator and the lowdensity lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112, 2787-2794.
184. Slaets, H., Dumont, D., Vanderlocht, J., Noben, J.P., Leprince, P., Robben, J., Hendriks, J., Stinissen, P., and Hellings, N. (2008) Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Aktphosphorylation and up-regulation of 14-3-3. Proteomics 8, 1237-1247.
185. Williams, R., Dhillon, N.K., Hegde, S.T., Yao, H., Peng, F., Callen, S., Chebloune, Y., Davis, R.L., and Buch, S.J. (2009) Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 57, 734-743.
186. Rodriguez-Blanco, J., Martin, V., Herrera, F., Garcia-Santos, G., Antolin, I., and Rodriguez, C. (2008) Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine. J. Neurochem. 107, 127-140.
187. Anitha, M., Gondha, C., Sutliff, R., Parsadanian, A., Mwangi, S., Sitaraman, S.V., and Srinivasan, S. (2006) GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J. Clin. Invest. 116, 344-356.
188. Gaddini, L., Villa, M., Matteucci, A., Mallozzi, C., Petrucci, T.C., Di Stasi, A.M., Leo, L., Malchiodi-Albedi, F., and Pricci, F. (2009) Early effects of high glucose in retinal tissue cultures Renin-Angiotensin system-dependent and - independent signaling. Neurobiol. Dis. 35, 278-285.
189. Burgos-Ramos, E., Martos-Moreno, G.A., Lopez, M.G., Herranz, R., Aguado-Llera, D., Egea, J., Frechilla, D., Cenarruzabeitia, E., Leon, R., Arilla-Ferreiro, E., Argente, J., and Barrios, V. (2009) The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulation. J. Neurochem. 109, 360-370.
190. Burgos-Ramos, E., Puebla-Jimenez, L., and Arilla-Ferreiro, E. (2008) Minocycline provides protection against betaamyloid( 25-35)-induced alterations of the somatostatin signaling pathway in the rat temporal cortex. Neuroscience 154, 1458-1466.
191. Burgos-Ramos, E., Puebla-Jimenez, L., and Arilla-Ferreiro, E. (2009) Minocycline prevents Abeta(25-35)-induced reduction of somatostatin and neprilysin content in rat temporal cortex. Life Sci. 84, 205-210.
192. Chong, Z.Z., Li, F., and Maiese, K. (2005) Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr. Neurovasc. Res. 2, 387-399.
193. Campos-Esparza, M.R., Sanchez-Gomez, M.V., and Matute, C. (2009) Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium 45, 358-368.
194. Kim, K.H., Oudit, G.Y., and Backx, P.H. (2008) Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J. Pharmacol. Exp. Ther. 324, 160-169.
195. Tajes, M., Yeste-Velasco, M., Zhu, X., Chou, S.P., Smith, M.A., Pallas, M., Camins, A., and Casadesus, G. (2009) Activation of Akt by lithium: pro-survival pathways in aging. Mech. Ageing Dev. 130, 253-261.
196. van der Heide, L.P., Jacobs, F.M., Burbach, J.P., Hoekman, M.F., and Smidt, M.P. (2005) FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling. Biochem. J. 391, 623-629.
197. Maiese, K., Chong, Z.Z., and Li, F. (2005) Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Curr. Neurovasc. Res. 2, 425-446.
198. Salvesen, G.S. and Riedl, S.J. (2008) Caspase mechanisms. Adv. Exp. Med. Biol. 615, 13-23.
199. Chong, Z.Z., Li, F., and Maiese, K. (2006) Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress. Curr. Neurovasc. Res. 3, 107-117.
200. Chong, Z.Z., Lin, S.H., and Maiese, K. (2004) The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J. Cereb. Blood Flow Metab. 24, 728-743.
201. Obexer, P., Geiger, K., Ambros, P.F., Meister, B., and Ausserlechner, M.J. (2007) FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14, 534-547.
202. Gomez-Gutierrez, J.G., Souza, V., Hao, H.Y., Montes de Oca-Luna, R., Dong, Y.B., Zhou, H.S., and McMasters, K.M. (2006) Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol. Ther. 5, 875-883.
203. Maiese, K., Chong, Z.Z., and Shang, Y.C. (2007) Mechanistic insights into diabetes mellitus and oxidative stress. Curr. Med. Chem. 14, 1729-1738.
204. Maiese, K., Morhan, S.D., and Chong, Z.Z. (2007) Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr. Neurovasc. Res. 4, 63-71.
205. Maiese, K. (2008) Diabetic stress: new triumphs and challenges to maintain vascular longevity. Expert Rev. Cardiovasc. Ther. 6, 281-284.
206. Hao, J., Shen, W., Tian, C., Liu, Z., Ren, J., Luo, C., Long, J., Sharman, E., and Liu, J. (2009) Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J. Cell. Mol. Med. 13, 701-711.
207. Kuhad, A., Bishnoi, M., Tiwari, V., and Chopra, K. (2009) Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol. Biochem. Behav. 92, 251-259.
208. Wu, S.Y., Wang, G.F., Liu, Z.Q., Rao, J.J., Lu, L., Xu, W., Wu, S.G., and Zhang, J.J. (2009) Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Acta Pharmacol. Sin. 30, 202-208.
209. Guarnieri, G., Zanetti, M., Vinci, P., Cattin, M.R., and Barazzoni, R. (2009) Insulin resistance in chronic uremia. J. Ren. Nutr. 19, 20-24.
210. Gossai, D. and Lau-Cam, C.A. (2009) The effects of taurine, taurine homologs and hypotaurine on cell and membrane antioxidative system alterations caused by type 2 diabetes in rat erythrocytes. Adv. Exp. Med. Biol. 643, 359-368.
211. Donahoe, S.M., Stewart, G.C., McCabe, C.H., Mohanavelu, S., Murphy, S.A., Cannon, C.P., and Antman, E.M. (2007) Diabetes and mortality following acute coronary syndromes. JAMA 298, 765-775.
212. Mojiminiyi, O.A., Abdella, N.A., Zaki, M.Y., El Gebely, S.A., Mohamedi, H.M., and Aldhahi, W.A. (2006) Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus. Diabet. Med. 23, 839-844.
213. Symeonidis, A., Kouraklis-Symeonidis, A., Psiroyiannis, A., Leotsinidis, M., Kyriazopoulou, V., Vassilakos, P., Vagenakis, A., and Zoumbos, N. (2006) Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus. Ann. Hematol. 85, 79-85.
214. Thomas, M.C., Cooper, M.E., Tsalamandris, C., MacIsaac, R., and Jerums, G. (2005) Anemia with impaired erythropoietin response in diabetic patients. Arch. Intern. Med. 165, 466-469.
215. Teramo, K., Kari, M.A., Eronen, M., Markkanen, H., and Hiilesmaa, V. (2004) High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 47, 1695-1703.
216. Duarte, A.I., Proenca, T., Oliveira, C.R., Santos, M.S., and Rego, A.C. (2006) Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 55, 2863-2870.
217. Silverberg, D.S., Wexler, D., Iaina, A., and Schwartz, D. (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin. Nephrol. 26, 296-306.
218. Chong, Z.Z., Shang, Y.C., and Maiese, K. (2007) Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr. Neurovasc. Res. 4, 194-204.
219. Mason-Garcia, M., Beckman, B.S., Brookins, J.W., Powell, J.S., Lanham, W., Blaisdell, S., Keay, L., Li, S.C., and Fisher, J.W. (1990) Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin. Kidney Int. 38, 969-975.
220. Namiuchi, S., Kagaya, Y., Ohta, J., Shiba, N., Sugi, M., Oikawa, M., Kunii, H., Yamao, H., Komatsu, N., Yui, M., Tada, H., Sakuma, M., Watanabe, J., Ichihara, T., and Shirato, K. (2005) High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J. Am. Coll. Cardiol. 45, 1406-1412.
221. Chattopadhyay, M., Walter, C., Mata, M., and Fink, D.J. (2009) Neuroprotective effect of herpes simplex virusmediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Brain 132, 879-888.
222. Avasarala, J.R. and Konduru, S.S. (2005) Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis. J. Mol. Neurosci. 25, 183-189.
223. Miki, T., Miura, T., Yano, T., Takahashi, A., Sakamoto, J., Tanno, M., Kobayashi, H., Ikeda, Y., Nishihara, M., Naitoh, K., Ohori, K., and Shimamoto, K. (2006) Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling. J. Pharmacol. Exp. Ther. 317, 68-75.
224. Espada, J., Calvo, M.B., Diaz-Prado, S., and Medina, V. (2009) Wnt signalling and cancer stem cells. Clin. Transl. Oncol. 11, 411-427.
225. Wilusz, M. and Majka, M. (2008) Role of the Wnt/beta-catenin network in regulating hematopoiesis. Arch. Immunol. Ther. Exp. (Warsz.) 56, 257-266.
226. Maiese, K., Li, F., Chong, Z.Z., and Shang, Y.C. (2008) The Wnt signaling pathway: aging gracefully as a protectionist? Pharmacol. Ther. 118, 58-81.
227. Kikuchi, A., Yamamoto, H., and Sato, A. (2009) Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol. 19, 119-129.
228. Grant, S.F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K.P., Walters, G.B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R.L., Reilly, M.P., Rader, D.J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J.R., Kong, A., and Stefansson, K. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320-323.
229. Lehman, D.M., Hunt, K.J., Leach, R.J., Hamlington, J., Arya, R., Abboud, H.E., Duggirala, R., Blangero, J., Goring, H.H., and Stern, M.P. (2007) Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56, 389-393.
230. Scott, L.J., Bonnycastle, L.L., Willer, C.J., Sprau, A.G., Jackson, A.U., Narisu, N., Duren, W.L., Chines, P.S., Stringham, H.M., Erdos, M.R., Valle, T.T., Tuomilehto, J., Bergman, R.N., Mohlke, K.L., Collins, F.S., and Boehnke, M. (2006) Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55, 2649-2653.
231. Guo, Y.F., Xiong, D.H., Shen, H., Zhao, L.J., Xiao, P., Guo, Y., Wang, W., Yang, T.L., Recker, R.R., and Deng, H.W. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J. Med. Genet. 43, 798-803.
232. Wright, W.S., Longo, K.A., Dolinsky, V.W., Gerin, I., Kang, S., Bennett, C.N., Chiang, S.H., Prestwich, T.C., Gress, C., Burant, C.F., Susulic, V.S., and Macdougald, O.A. (2007) Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 56, 295-303.
233. Lin, C.L., Wang, J.Y., Huang, Y.T., Kuo, Y.H., Surendran, K., and Wang, F.S. (2006) Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J. Am. Soc. Nephrol. 17, 2812-2820.
234. Lin, K., Dorman, J.B., Rodan, A., and Kenyon, C. (1997) daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319-1322.
235. Ogg, S., Paradis, S., Gottlieb, S., Patterson, G.I., Lee, L., Tissenbaum, H.A., and Ruvkun, G. (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-999.
236. Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., and Unterman, T. (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274, 17184-17192.
237. Nakae, J., Park, B.C., and Accili, D. (1999) Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem. 274, 15982-15985.
238. Kim, J.R., Jung, H.S., Bae, S.W., Kim, J.H., Park, B.L., Choi, Y.H., Cho, H.Y., Cheong, H.S., and Shin, H.D. (2006) Polymorphisms in FOXO gene family and association analysis with BMI. Obesity (Silver Spring) 14, 188-193.
239. Marchetti, V., Menghini, R., Rizza, S., Vivanti, A., Feccia, T., Lauro, D., Fukamizu, A., Lauro, R., and Federici, M. (2006) Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 55, 2231-2237.
240. Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Belladonna, M.L., Fioretti, M.C., Serreze, D.V., Grohmann, U., and Puccetti, P. (2004) CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J. Exp. Med. 200, 1051-1062.
241. Nakae, J., Cao, Y., Oki, M., Orba, Y., Sawa, H., Kiyonari, H., Iskandar, K., Suga, K., Lombes, M., and Hayashi, Y. (2008) Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 57, 563-576.
242. Puig, O. and Tjian, R. (2005) Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435-2446.
243. Kamagate, A. and Dong, H.H. (2008) Foxo1 integrates insulin signaling to VLDL production. Cell Cycle 7, 3162-3170.
244. Ni, Y.G., Wang, N., Cao, D.J., Sachan, N., Morris, D.J., Gerard, R.D., Kuro, O.M., Rothermel, B.A., and Hill, J.A. (2007) FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc. Natl. Acad. Sci. U. S. A. 104, 20517-20522.
245. Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H., Nishino, I., and Ezaki, O. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279, 41114-41123.
246. Liu, C.M., Yang, Z., Liu, C.W., Wang, R., Tien, P., Dale, R., and Sun, L.Q. (2007) Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice. Cancer Gene Ther. 14, 945-952.
247. Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z.P., Lecker, S.H., Goldberg, A.L., and Spiegelman, B.M. (2006) PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. U. S. A. 103, 16260-16265.
248. Maiese, K., Chong, Z.Z., Hou, J., and Shang, Y. (2009) The vitamin nicotinamide: translating nutrition into clinical care. Molecules 14, 3446-3485.
249. Balan, V., Miller, G.S., Kaplun, L., Balan, K., Chong, Z.Z., Li, F., Kaplun, A., VanBerkum, M.F., Arking, R., Freeman, D.C., Maiese, K., and Tzivion, G. (2008) Life span extension and neuronal cell protection by Drosophila nicotinamidase. J. Biol. Chem. 283, 27810-27819.
250. Chong, Z.Z. and Maiese, K. (2008) Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr. Neurovasc. Res. 5, 159-170.
251. Solar, P., Koval, J., Mikes, J., Kleban, J., Solarova, Z., Lazur, J., Hodorova, I., Fedorocko, P., and Sytkowski, A.J. (2008) Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells. Mol. Cancer Ther. 7, 2263-2271.
252. Sauvageot, C.M., Kesari, S., and Stiles, C.D. (2007) Molecular pathogenesis of adult brain tumors and the role of stem cells. Neurol. Clin. 25, 891-924, vii.
253. Anagnostou, A., Lee, E.S., Kessimian, N., Levinson, R., and Steiner, M. (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 87, 5978-5982.
254. Ashley, R.A., Dubuque, S.H., Dvorak, B., Woodward, S.S., Williams, S.K., and Kling, P.J. (2002) Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr. Res. 51, 472-478.
255. Li, Y., Lu, Z., Keogh, C.L., Yu, S.P., and Wei, L. (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J. Cereb. Blood Flow Metab. 27, 1043-1054.
256. Reinders, M.E., Rabelink, T.J., and Briscoe, D.M. (2006) Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J. Am. Soc. Nephrol. 17, 932-942.
257. Zhang, D., Zhang, F., Zhang, Y., Gao, X., Li, C., Ma, W., and Cao, K. (2007) Erythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarction. Cardiology 108, 228-236.
258. Zhang, S.X. and Ma, J.X. (2007) Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog. Retin. Eye Res. 26, 1-37.
259. Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A.M., and Dimmeler, S. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346.
260. Koh, S.H., Noh, M.Y., Cho, G.W., Kim, K.S., and Kim, S.H. (2009) Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBMMSCs. Stem Cells Dev. 18, 411-421.
261. Brunner, S., Winogradow, J., Huber, B.C., Zaruba, M.M., Fischer, R., David, R., Assmann, G., Herbach, N., Wanke, R., Mueller-Hoecker, J., and Franz, W.M. (2009) Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB J. 23, 351-361.
262. Lin, J.S., Chen, Y.S., Chiang, H.S., and Ma, M.C. (2008) Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. J. Physiol. 586, 5757-5769.
263. Uitterdijk, A., Groenendijk, B.C., and van Der Giessen, W.J. (2009) Stem cell therapy for chronic heart failure. Hellenic J. Cardiol. 50, 127-132.
264. Bakker, W.J., van Dijk, T.B., Parren-van Amelsvoort, M., Kolbus, A., Yamamoto, K., Steinlein, P., Verhaak, R.G., Mak, T.W., Beug, H., Lowenberg, B., and von Lindern, M. (2007) Differential regulation of Foxo3a target genes in erythropoiesis. Mol. Cell. Biol. 27, 3839-3854.
265. Cariou, A., Claessens, Y.E., Pene, F., Marx, J.S., Spaulding, C., Hababou, C., Casadevall, N., Mira, J.P., Carli, P., and Hermine, O. (2008) Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 76, 397-404.
266. Miyamoto, K., Araki, K.Y., Naka, K., Arai, F., Takubo, K., Yamazaki, S., Matsuoka, S., Miyamoto, T., Ito, K., Ohmura, M., Chen, C., Hosokawa, K., Nakauchi, H., Nakayama, K., Nakayama, K.I., Harada, M., Motoyama, N., Suda, T., and Hirao, A. (2007) Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1, 101-112.
267. Tothova, Z., Kollipara, R., Huntly, B.J., Lee, B.H., Castrillon, D.H., Cullen, D.E., McDowell, E.P., Lazo-Kallanian, S., Williams, I.R., Sears, C., Armstrong, S.A., Passegue, E., DePinho, R.A., and Gilliland, D.G. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339.
268. Furukawa-Hibi, Y., Yoshida-Araki, K., Ohta, T., Ikeda, K., and Motoyama, N. (2002) FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J. Biol. Chem. 277, 26729-26732.
269. Liu, L., Rajareddy, S., Reddy, P., Du, C., Jagarlamudi, K., Shen, Y., Gunnarsson, D., Selstam, G., Boman, K., and Liu, K. (2007) Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134, 199-209.
270. Watkins, W.J., Umbers, A.J., Woad, K.J., Harris, S.E., Winship, I.M., Gersak, K., and Shelling, A.N. (2006) Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil. Steril. 86, 1518-1521.
271. Wu, Y., Peng, H., Cui, M., Whitney, N.P., Huang, Y., and Zheng, J.C. (2009) CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J. Neurochem. 109, 1157-1167.
272. Hosaka, T., Biggs, W.H., 3rd, Tieu, D., Boyer, A.D., Varki, N.M., Cavenee, W.K., and Arden, K.C. (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A. 101, 2975-2980.
273. Furuyama, T., Kitayama, K., Shimoda, Y., Ogawa, M., Sone, K., Yoshida-Araki, K., Hisatsune, H., Nishikawa, S., Nakayama, K., Nakayama, K., Ikeda, K., Motoyama, N., and Mori, N. (2004) Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279, 34741-34749.
274. Evans-Anderson, H.J., Alfieri, C.M., and Yutzey, K.E. (2008) Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ. Res. 102, 686-694.
275. Li, H.H., Willis, M.S., Lockyer, P., Miller, N., McDonough, H., Glass, D.J., and Patterson, C. (2007) Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of forkhead proteins. J. Clin. Invest. 117, 3211-3223.
276. Abid, M.R., Yano, K., Guo, S., Patel, V.I., Shrikhande, G., Spokes, K.C., Ferran, C., and Aird, W.C. (2005) Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J. Biol. Chem. 280, 29864-29873.
277. Liu, Z.P., Wang, Z., Yanagisawa, H., and Olson, E.N. (2005) Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 9, 261-270.
278. Li, H., Liang, J., Castrillon, D.H., DePinho, R.A., Olson, E.N., and Liu, Z.P. (2007) FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 27, 2676-2686.
279. Goettsch, W., Gryczka, C., Korff, T., Ernst, E., Goettsch, C., Seebach, J., Schnittler, H.J., Augustin, H.G., and Morawietz, H. (2008) Flow-dependent regulation of angiopoietin-2. J. Cell. Physiol. 214, 491-503.
280. Morris, J.B., Kenney, B., Huynh, H., and Woodcock, E.A. (2005) Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists. Endocrinology 146, 4370-4376.
281. Sedding, D.G., Seay, U., Fink, L., Heil, M., Kummer, W., Tillmanns, H., and Braun-Dullaeus, R.C. (2003) Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation 108, 616-622.
282. Hannenhalli, S., Putt, M.E., Gilmore, J.M., Wang, J., Parmacek, M.S., Epstein, J.A., Morrisey, E.E., Margulies, K.B., and Cappola, T.P. (2006) Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 114, 1269-1276.
283. Liu, R., Suzuki, A., Guo, Z., Mizuno, Y., and Urabe, T. (2006) Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J. Neurochem. 96, 1101-1110.
284. Meloni, B.P., Tilbrook, P.A., Boulos, S., Arthur, P.G., and Knuckey, N.W. (2006) Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis. J. Neurosci. Res. 83, 584-593.
285. Wei, L., Han, B.H., Li, Y., Keogh, C.L., Holtzman, D.M., and Yu, S.P. (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J. Pharmacol. Exp. Ther. 317, 109-116.
286. Yu, Y.P., Xu, Q.Q., Zhang, Q., Zhang, W.P., Zhang, L.H., and Wei, E.Q. (2005) Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci. Lett. 387, 5-10.
287. Montero, M., Poulsen, F.R., Noraberg, J., Kirkeby, A., van Beek, J., Leist, M., and Zimmer, J. (2007) Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygenglucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp. Neurol. 204, 106-117.
288. Yamasaki, M., Mishima, H.K., Yamashita, H., Kashiwagi, K., Murata, K., Minamoto, A., and Inaba, T. (2005) Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 1050, 15-26.
289. Yoo, J.Y., Won, Y.J., Lee, J.H., Kim, J.U., Sung, I.Y., Hwang, S.J., Kim, M.J., and Hong, H.N. (2009) Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures. J. Neurosci. Res. 87, 150-163.
290. Bienvenu, A.L., Ferrandiz, J., Kaiser, K., Latour, C., and Picot, S. (2008) Artesunate-erythropoietin combination for murine cerebral malaria treatment. Acta Trop. 106, 104-108.
291. Casals-Pascual, C., Idro, R., Picot, S., Roberts, D.J., and Newton, C.R. (2009) Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol. 25, 30-36.
292. Kaiser, K., Texier, A., Ferrandiz, J., Buguet, A., Meiller, A., Latour, C., Peyron, F., Cespuglio, R., and Picot, S. (2006) Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J. Infect. Dis. 193, 987-995.
293. Aoshiba, K., Onizawa, S., Tsuji, T., and Nagai, A. (2009) Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit. Care Med. 37, 889-898.
294. Wagner, F., Baumgart, K., Simkova, V., Georgieff, M., Radermacher, P., and Calzia, E. (2008) Year in review 2007: Critical Care--shock. Crit. Care 12, 227.
295. Chen, H.H., Tarng, D.C., Lee, K.F., Wu, C.Y., and Chen, Y.C. (2008) Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease. J. Nephrol. 21, 543-549.
296. Mao, W., Iwai, C., Liu, J., Sheu, S.S., Fu, M., and Liang, C.S. (2008) Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways. J. Mol. Cell. Cardiol. 45, 250-260.
297. Ma, R., Xiong, N., Huang, C., Tang, Q., Hu, B., Xiang, J., and Li, G. (2009) Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 56, 1027-1034.
298. Sun, Z.K., Yang, H.Q., Pan, J., Zhen, H., Wang, Z.Q., Chen, S.D., and Ding, J.Q. (2008) Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid. J. Neurosci. Res. 86, 3018-3027.
299. Ucan, B.H., Irkorucu, O., Cakmak, G.K., Tascilar, O., Tekin, I.O., Acikgoz, S., Emre, A.U., Bahadir, B., Ankarali, H., and Comert, M. (2009) Erythropoietin: a possible cytoprotective cytokine in acute necrotizing pancreatitis. J. Hepatobiliary Pancreat. Surg. 16, 530-537.
300. Tascilar, O., Cakmak, G.K., Tekin, I.O., Emre, A.U., Ucan, B.H., Bahadir, B., Acikgoz, S., Irkorucu, O., Karakaya, K., Balbaloglu, H., Kertis, G., Ankarali, H., and Comert, M. (2007) Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis. World J. Gastroenterol. 13, 6172-6182.
301. Wu, H., Dong, G., Liu, H., Xu, B., Li, D., and Jing, H. (2009) Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur. J. Pharmacol. 602, 406-412.
302. Chen, J., Connor, K.M., Aderman, C.M., Willett, K.L., Aspegren, O.P., and Smith, L.E. (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 50, 1329-1335.
303. Wang, Z.Y., Shen, L.J., Tu, L., Hu, D.N., Liu, G.Y., Zhou, Z.L., Lin, Y., Chen, L.H., and Qu, J. (2009) Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radic. Biol. Med. 46, 1032-1041.
304. Zhong, Y., Yao, H., Deng, L., Cheng, Y., and Zhou, X. (2007) Promotion of neurite outgrowth and protective effect of erythropoietin on the retinal neurons of rats. Graefes Arch. Clin. Exp. Ophthalmol. 245, 1859-1867.
305. Zhong, Y.S., Liu, X.H., Cheng, Y., and Min, Y.J. (2008) Erythropoietin with retrobulbar administration protects retinal ganglion cells from acute elevated intraocular pressure in rats. J. Ocul. Pharmacol. Ther. 24, 453-459.
306. Tsai, J.C., Song, B.J., Wu, L., and Forbes, M. (2007) Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma. J. Glaucoma 16, 567-571.
307. King, V.R., Averill, S.A., Hewazy, D., Priestley, J.V., Torup, L., and Michael-Titus, A.T. (2007) Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur. J. Neurosci. 26, 90-100.
308. Okutan, O., Solaroglu, I., Beskonakli, E., and Taskin, Y. (2007) Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. J. Clin. Neurosci. 14, 364-368.
309. Verdonck, O., Lahrech, H., Francony, G., Carle, O., Farion, R., Van de Looij, Y., Remy, C., Segebarth, C., and Payen, J.F. (2007) Erythropoietin protects from post-traumatic edema in the rat brain. J. Cereb. Blood Flow Metab. 27, 1369-1376.
310. Cherian, L., Goodman, J.C., and Robertson, C. (2007) Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J. Pharmacol. Exp. Ther. 322, 789-794.
311. Chu, K., Jung, K.H., Lee, S.T., Kim, J.H., Kang, K.M., Kim, H.K., Lim, J.S., Park, H.K., Kim, M., Lee, S.K., and Roh, J.K. (2008) Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 49, 1723-1732.
312. Nadam, J., Navarro, F., Sanchez, P., Moulin, C., Georges, B., Laglaine, A., Pequignot, J.M., Morales, A., Ryvlin, P., and Bezin, L. (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol. Dis. 25, 412-426.
313. Nakamura, T. and Sakamoto, K. (2007) Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Mol. Cell. Endocrinol. 281(1-2), 47-55.
314. Barthelemy, C., Henderson, C.E., and Pettmann, B. (2004) Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci. 5, 48.
315. You, H., Yamamoto, K., and Mak, T.W. (2006) Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl. Acad. Sci. U. S. A. 103, 9051-9056.
316. Won, C.K., Ji, H.H., and Koh, P.O. (2006) Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci. Lett. 398, 39-43.
317. Caporali, A., Sala-Newby, G.B., Meloni, M., Graiani, G., Pani, E., Cristofaro, B., Newby, A.C., Madeddu, P., and Emanueli, C. (2008) Identification of the prosurvival activity of nerve growth factor on cardiac myocytes. Cell Death Differ. 15, 299-311.
318. Erol, A. (2009) Unraveling the molecular mechanisms behind the metabolic basis of sporadic Alzheimer's disease. J. Alzheimers Dis. [Epub ahead of print]
319. Lu, J., Wu, D.M., Zheng, Y.L., Sun, D.X., Hu, B., Shan, Q., Zhang, Z.F., and Fan, S.H. (2009) Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Brain Behav. Immun. 23, 193-203.
320. Majd, S., Rastegar, K., Zarifkar, A., and Takhshid, M.A. (2007) Fibrillar beta-amyloid (Abeta) (1-42) elevates extracellular Abeta in cultured hippocampal neurons of adult rats. Brain Res. 1185, 321-327.
321. Majd, S., Zarifkar, A., Rastegar, K., and Takhshid, M.A. (2008) Different fibrillar Abeta 1-42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle. Brain Res. 1218, 224-229.
322. Smith, W.W., Norton, D.D., Gorospe, M., Jiang, H., Nemoto, S., Holbrook, N.J., Finkel, T., and Kusiak, J.W. (2005) Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J. Cell Biol. 169, 331-339.
323. Mercado-Gomez, O., Hernandez-Fonseca, K., Villavicencio-Queijeiro, A., Massieu, L., Chimal-Monroy, J., and Arias, C. (2008) Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation. Neurochem. Res. 33, 1599-1609.
324. Slotkin, T.A. and Seidler, F.J. (2009) Protein kinase C is a target for diverse developmental neurotoxicants: transcriptional responses to chlorpyrifos, diazinon, dieldrin and divalent nickel in PC12 cells. Brain Res. 1263, 23-32.
325. Slotkin, T.A., Seidler, F.J., and Fumagalli, F. (2008) Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro. Brain Res. Bull. 76, 424-438.
326. Hoogeboom, D., Essers, M.A., Polderman, P.E., Voets, E., Smits, L.M., and Burgering, B.M. (2008) Interaction of FOXO with {beta}-catenin inhibits {beta}-catenin/T cell factor activity. J. Biol. Chem. 283, 9224-9230.
327. Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., Rengo, G., Rossi, F., and Filippelli, A. (2008) Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 11(1), 139-150.
328. Gilfillan, A.M. and Rivera, J. (2009) The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 228, 149-169.
329. Li, F., Chong, Z.Z., and Maiese, K. (2005) Vital elements of the wnt-frizzled signaling pathway in the nervous system. Curr. Neurovasc. Res. 2, 331-340.
330. Dringen, R. (2005) Oxidative and antioxidative potential of brain microglial cells. Antioxid. Redox Signal. 7, 1223-1233.
331. Sankarapandi, S., Zweier, J.L., Mukherjee, G., Quinn, M.T., and Huso, D.L. (1998) Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys. 353, 312-321.
332. Mehlhorn, G., Hollborn, M., and Schliebs, R. (2000) Induction of cytokines in glial cells surrounding cortical betaamyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int. J. Dev. Neurosci. 18, 423-431.
333. Benzing, W.C., Wujek, J.R., Ward, E.K., Shaffer, D., Ashe, K.H., Younkin, S.G., and Brunden, K.R. (1999) Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol. Aging 20, 581-589.
334. Ferri, C., Giuggioli, D., Sebastiani, M., and Colaci, M. (2007) Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin. Exp. Dermatol. 32, 287-290.
335. Thorne, M., Moore, C.S., and Robertson, G.S. (2009) Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: effects of darbepoetin alfa on TIMP-1 null and wild-type mice. J. Neuroimmunol. 211, 92-100.
336. Cuzzocrea, S., Mazzon, E., di Paola, R., Genovese, T., Patel, N.S., Britti, D., de Majo, M., Caputi, A.P., and Thiemermann, C. (2005) Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Arthritis Rheum. 52, 940-950.
337. Wu, Y., Shang, Y., Sun, S., Liang, H., and Liu, R. (2007) Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12, 1365-1375.
338. Li, F., Chong, Z.Z., and Maiese, K. (2004) Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13, 265-289.
339. Contaldo, C., Meier, C., Elsherbiny, A., Harder, Y., Trentz, O., Menger, M.D., and Wanner, G.A. (2007) Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice. Am. J. Physiol. Heart Circ. Physiol. 293, H274-283.
340. Vairano, M., Dello Russo, C., Pozzoli, G., Battaglia, A., Scambia, G., Tringali, G., Aloe-Spiriti, M.A., Preziosi, P., and Navarra, P. (2002) Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur. J. Neurosci. 16, 584-592.
341. Cools, N., Ponsaerts, P., Van Tendeloo, V.F., and Berneman, Z.N. (2007) Regulatory T cells and human disease. Clin. Dev. Immunol. 2007, 89195.
342. Ebert, L.M., Tan, B.S., Browning, J., Svobodova, S., Russell, S.E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S.P., MacGregor, D., Davis, I.D., Cebon, J., and Chen, W. (2008) The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res. 68, 3001-3009.
343. Kono, K., Kawaida, H., Takahashi, A., Sugai, H., Mimura, K., Miyagawa, N., Omata, H., and Fujii, H. (2006) CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol. Immunother. 55, 1064-1071.
344. Sela, U., Dayan, M., Hershkoviz, R., Cahalon, L., Lider, O., and Mozes, E. (2006) The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses. Eur. J. Immunol. 36, 2971-2980.
345. Bosque, A., Aguilo, J.I., Alava, M.A., Paz-Artal, E., Naval, J., Allende, L.M., and Anel, A. (2007) The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling. Blood 109, 1627-1635.
346. Lin, L., Hron, J.D., and Peng, S.L. (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203-213.
347. Jonsson, H., Allen, P., and Peng, S.L. (2005) Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 11, 666-671.
348. Ludikhuize, J., de Launay, D., Groot, D., Smeets, T.J., Vinkenoog, M., Sanders, M.E., Tas, S.W., Tak, P.P., and Reedquist, K.A. (2007) Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum. 56, 2180-2191.
349. Kuo, C.C. and Lin, S.C. (2007) Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Mol. Med. 13, 561-566.
350. Fabre, S., Carrette, F., Chen, J., Lang, V., Semichon, M., Denoyelle, C., Lazar, V., Cagnard, N., Dubart-Kupperschmitt, A., Mangeney, M., Fruman, D.A., and Bismuth, G. (2008) FOXO1 regulates L-selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J. Immunol. 181, 2980-2989.
351. Kikuchi, S., Nagai, T., Kunitama, M., Kirito, K., Ozawa, K., and Komatsu, N. (2007) Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factorrelated apoptosis-inducing ligand. Cancer Sci. 98, 1949-1958.
352. Nowak, K., Killmer, K., Gessner, C., and Lutz, W. (2007) E2F-1 regulates expression of FOXO1 and FOXO3a. Biochim. Biophys. Acta 1769, 244-252.
353. Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., and Schmitt, C.A. (2007) FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. Genes Dev. 21, 2775-2787.
354. Lynch, R.L., Konicek, B.W., McNulty, A.M., Hanna, K.R., Lewis, J.E., Neubauer, B.L., and Graff, J.R. (2005) The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol. Cancer Res. 3, 163-169.
355. Li, Y., Wang, Z., Kong, D., Murthy, S., Dou, Q.P., Sheng, S., Reddy, G.P., and Sarkar, F.H. (2007) Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J. Biol. Chem. 282, 21542-21550.
356. Cornforth, A.N., Davis, J.S., Khanifar, E., Nastiuk, K.L., and Krolewski, J.J. (2008) FOXO3a mediates the androgendependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene 27, 4422-4433.
357. Yang, L., Xie, S., Jamaluddin, M.S., Altuwaijri, S., Ni, J., Kim, E., Chen, Y.T., Hu, Y.C., Wang, L., Chuang, K.H., Wu, C.T., and Chang, C. (2005) Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J. Biol. Chem. 280, 33558-33565.
358. Liu, P., Kao, T.P., and Huang, H. (2008) CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 27, 4733-4744.
359. Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K., Hirata, H., Tanaka, Y., Place, R.F., Pookot, D., Majid, S., Igawa, M., and Dahiya, R. (2007) Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26, 7647-7655.
360. Trotman, L.C., Alimonti, A., Scaglioni, P.P., Koutcher, J.A., Cordon-Cardo, C., and Pandolfi, P.P. (2006) Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441, 523-527.
361. Jin, G.S., Kondo, E., Miyake, T., Shibata, M., Takashima, T., Liu, Y.X., Hayashi, K., Akagi, T., and Yoshino, T. (2004) Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. Acta Med. Okayama 58, 197-205.
362. Hu, M.C., Lee, D.F., Xia, W., Golfman, L.S., Ou-Yang, F., Yang, J.Y., Zou, Y., Bao, S., Hanada, N., Saso, H., Kobayashi, R., and Hung, M.C. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225-237.
363. Sunters, A., Madureira, P.A., Pomeranz, K.M., Aubert, M., Brosens, J.J., Cook, S.J., Burgering, B.M., Coombes, R.C., and Lam, E.W. (2006) Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res. 66, 212-220.
364. Eddy, S.F., Kane, S.E., and Sonenshein, G.E. (2007) Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res. 67, 9018-9023.
365. Zou, Y., Tsai, W.B., Cheng, C.J., Hsu, C., Chung, Y.M., Li, P.C., Lin, S.H., and Hu, M.C. (2008) Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res. 10, R21.
366. Paik, J.H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J.W., Carrasco, D.R., Jiang, S., Gilliland, D.G., Chin, L., Wong, W.H., Castrillon, D.H., and DePinho, R.A. (2007) FoxOs are lineagerestricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323.
367. Delpuech, O., Griffiths, B., East, P., Essafi, A., Lam, E.W., Burgering, B., Downward, J., and Schulze, A. (2007) Induction of Mxi1-SR{alpha} by FOXO3a contributes to repression of Myc-dependent gene expression. Mol. Cell. Biol. 27, 4917-4930.
368. Ticchioni, M., Essafi, M., Jeandel, P.Y., Davi, F., Cassuto, J.P., Deckert, M., and Bernard, A. (2007) Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 26, 7081-7091.
369. Munoz-Fontela, C., Marcos-Villar, L., Gallego, P., Arroyo, J., Da Costa, M., Pomeranz, K.M., Lam, E.W., and Rivas, C. (2007) Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor. J. Virol. 81, 1511-1516.
370. Hoekstra, A.V., Ward, E.C., Hardt, J.L., Lurain, J.R., Singh, D.K., Buttin, B.M., Schink, J.C., and Kim, J.J. (2008) Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecol. Oncol. 108, 609-618.
371. Donohue, J.M., Cevasco, M., and Rosenthal, M.B. (2007) A decade of direct-to-consumer advertising of prescription drugs. N. Engl. J. Med. 357, 673-681.
372. Mocini, D., Muso, P., Guendouz, E., De Marco, L., Mele, L., Cini, R., Sordini, P., Alois, A., Costantino, A., Arima, S., Gentili, C., and Santini, M. (2008) Endogenous erythropoietin and a single bolus of 40,000 IU of epoetin alpha do not protect the heart from ischaemia-reperfusion injury during extracorporeal circulation for cardiac surgery. Perfusion 23, 187-192.
373. Olea, F.D., Vera Janavel, G., De Lorenzi, A., Cuniberti, L., Yannarelli, G., Cabeza Meckert, P., Cearras, M., Laguens, R., and Crottogini, A. (2006) High-dose erythropoietin has no long-term protective effects in sheep with reperfused myocardial infarction. J. Cardiovasc. Pharmacol. 47, 736-741.
374. Goldberg, N., Lundin, A.P., Delano, B., Friedman, E.A., and Stein, R.A. (1992) Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am. Heart J. 124, 424-427.
375. Silverberg, D.S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., Laniado, S., and Iaina, A. (2001) The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J. Am. Coll. Cardiol. 37, 1775-1780.
376. Mancini, D.M., Katz, S.D., Lang, C.C., LaManca, J., Hudaihed, A., and Androne, A.S. (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107, 294-299.
377. Wu, H., Ren, B., Zhu, J., Dong, G., Xu, B., Wang, C., Zheng, X., and Jing, H. (2006) Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur. J. Cardiothorac. Surg. 29, 902-907.
378. Corwin, H.L., Gettinger, A., Fabian, T.C., May, A., Pearl, R.G., Heard, S., An, R., Bowers, P.J., Burton, P., Klausner, M.A., and Corwin, M.J. (2007) Efficacy and safety of epoetin alfa in critically ill patients. N. Engl. J. Med. 357, 965-976.
379. Ioka, T., Tsuruoka, S., Ito, C., Iwaguro, H., Asahara, T., Fujimura, A., and Kusano, E. (2009) Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients. Clin. Pharmacol. Ther. 86, 154-159.
380. van der Meer, P., Voors, A.A., Lipsic, E., Smilde, T.D., van Gilst, W.H., and van Veldhuisen, D.J. (2004) Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J. Am. Coll. Cardiol. 44, 63-67.
381. Reddy, M.K., Vasir, J.K., Hegde, G.V., Joshi, S.S., and Labhasetwar, V. (2007) Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury. J. Cardiovasc. Pharmacol. Ther. 12, 237-247.
382. Henry, D.H., Bowers, P., Romano, M.T., and Provenzano, R. (2004) Epoetin alfa. Clinical evolution of a pleiotropic cytokine. Arch. Intern. Med. 164, 262-276.
383. Kanbay, M., Akcay, A., Delibasi, T., Uz, B., Kaya, A., Koca, C., Turgut, F., Bavbek, N., Uz, E., Duranay, M., and Yigitoglu, R. (2007) Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure. Adv. Ther. 24, 346-352.
384. Kokhaei, P., Abdalla, A.O., Hansson, L., Mikaelsson, E., Kubbies, M., Haselbeck, A., Jernberg-Wiklund, H., Mellstedt, H., and Osterborg, A. (2007) Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies. Clin. Cancer Res. 13, 3536-3544.
385. Hardee, M.E., Rabbani, Z.N., Arcasoy, M.O., Kirkpatrick, J.P., Vujaskovic, Z., Dewhirst, M.W., and Blackwell, K.L. (2006) Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity. Mol. Cancer Ther. 5, 356-361.
386. Lai, S.Y. and Grandis, J.R. (2006) Understanding the presence and function of erythropoietin receptors on cancer cells. J. Clin. Oncol. 24, 4675-4676.
387. Ceelen, W., Boterberg, T., Smeets, P., Van Damme, N., Demetter, P., Zwaenepoel, O., Cesteleyn, L., Houtmeyers, P., Peeters, M., and Pattyn, P. (2007) Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels. Br. J. Cancer 96, 692-700.
388. Rades, D., Golke, H., Schild, S.E., and Kilic, E. (2008) The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. Int. J. Radiat. Oncol. Biol. Phys. 71, 152-159.
389. Ning, S., Hartley, C., Molineux, G., and Knox, S.J. (2005) Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia. Cancer Res. 65, 284-290.
390. Sigounas, G., Sallah, S., and Sigounas, V.Y. (2004) Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model. Cancer Lett. 214, 171-179.
391. Joyeux-Faure, M. (2007) Cellular protection by erythropoietin: new therapeutic implications? J. Pharmacol. Exp. Ther. 323, 759-762.
392. Baoutina, A., Alexander, I.E., Rasko, J.E., and Emslie, K.R. (2007) Potential use of gene transfer in athletic performance enhancement. Mol. Ther. 15, 1751-1766.
393. Diamanti-Kandarakis, E., Konstantinopoulos, P.A., Papailiou, J., Kandarakis, S.A., Andreopoulos, A., and Sykiotis, G.P. (2005) Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era. Sports Med. 35, 831-840.
394. Segura, J., Pascual, J.A., and Gutierrez-Gallego, R. (2007) Procedures for monitoring recombinant erythropoietin and analogues in doping control. Anal. Bioanal. Chem. 388, 1521-1529.
395. Frietsch, T., Maurer, M.H., Vogel, J., Gassmann, M., Kuschinsky, W., and Waschke, K.F. (2007) Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpressing transgenic mice with excessive erythrocytosis. J. Cereb. Blood Flow Metab. 27, 469-476.
396. Eliopoulos, N., Gagnon, R.F., Francois, M., and Galipeau, J. (2006) Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J. Am. Soc. Nephrol. 17, 1576-1584.
397. Orive, G., De Castro, M., Ponce, S., Hernandez, R.M., Gascon, A.R., Bosch, M., Alberch, J., and Pedraz, J.L. (2005) Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol. Ther. 12, 283-289.
398. Ponce, S., Orive, G., Hernandez, R.M., Gascon, A.R., Canals, J.M., Munoz, M.T., and Pedraz, J.L. (2006) In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J. Control Release 116, 28-34.
399. Doolittle, N.D., Peereboom, D.M., Christoforidis, G.A., Hall, W.A., Palmieri, D., Brock, P.R., Campbell, K.C., Dickey, D.T., Muldoon, L.L., O'Neill, B.P., Peterson, D.R., Pollock, B., Soussain, C., Smith, Q., Tyson, R.M., and Neuwelt, E.A. (2007) Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting. J. Neurooncol. 81, 81-91.
400. Gonzalez, F.F., McQuillen, P., Mu, D., Chang, Y., Wendland, M., Vexler, Z., and Ferriero, D.M. (2007) Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev. Neurosci. 29, 321-330.
401. Slevin, M., Kumar, P., Gaffney, J., Kumar, S., and Krupinski, J. (2006) Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin. Sci. (Lond.) 111, 171-183.
402. Ward, E.C., Hoekstra, A.V., Blok, L.J., Hanifi-Moghaddam, P., Lurain, J.R., Singh, D.K., Buttin, B.M., Schink, J.C., and Kim, J.J. (2008) The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Endocrinology 149, 1942-1950.
403. Hellwinkel, O.J., Rogmann, J.P., Asong, L.E., Luebke, A.M., Eichelberg, C., Ahyai, S., Isbarn, H., Graefen, M., Huland, H., and Schlomm, T. (2008) A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer. BJU Int. 101, 1454-1460.
404. Kim, J.H., Kim, M.K., Lee, H.E., Cho, S.J., Cho, Y.J., Lee, B.L., Lee, H.S., Nam, S.Y., Lee, J.S., and Kim, W.H. (2007) Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod. Pathol. 20, 835-842.
405. Zethelius, B., Berglund, L., Sundstrom, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., and Arnlov, J. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N. Engl. J. Med. 358, 2107-2116.
406. Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran, H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., Hu, L.S., Cheng, H.L., Jedrychowski, M.P., Gygi, S.P., Sinclair, D.A., Alt, F.W., and Greenberg, M.E. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015.
407. Bakker, W.J., Harris, I.S., and Mak, T.W. (2007) FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol. Cell 28, 941-953.
408. Han, C.Y., Cho, K.B., Choi, H.S., Han, H.K., and Kang, K.W. (2008) Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis 29, 1837-1844.
409. Emami, K.H. and Corey, E. (2007) When prostate cancer meets bone: control by wnts. Cancer Lett. 253, 170-179.